Abstract:Abstract Objective. A multi-discriminator-based cycle generative adversarial network (MD-CycleGAN) model is proposed to synthesize higher-quality pseudo-CT from MRI images. Approach. MRI and CT images obtained at the simulation stage with cervical cancer were selected to train the model. The generator adopted DenseNet as the main architecture. The local and global discriminators based on a convolutional neural network jointly discriminated the authenticity of the input image data. In the testing phase, the model was verified by a fourfold cross-validation method. In the prediction stage, the data were selected to evaluate the accuracy of the pseudo-CT in anatomy and dosimetry, and they were compared with the pseudo-CT synthesized by GAN with the generator based on the architectures of ResNet, sUNet, and FCN. Main results. There are significant differences ( P < 0.05) in the fourfold cross-validation results on the peak signal-to-noise ratio and structural similarity index metrics between the pseudo-CT obtained based on MD-CycleGAN and the ground truth CT (CT gt ). The pseudo-CT synthesized by MD-CycleGAN had closer anatomical information to the CT gt with a root mean square error of 47.83 ± 2.92 HU, a normalized mutual information value of 0.9014 ± 0.0212, and a mean absolute error value of 46.79 ± 2.76 HU. The differences in dose distribution between the pseudo-CT obtained by MD-CycleGAN and the CT gt were minimal. The mean absolute dose errors of Dose max , Dose min , and Dose mean based on the planning target volume were used to evaluate the dose uncertainty of the four pseudo-CT. The u-values of the Wilcoxon test were 55.407, 41.82, and 56.208, and the differences were statistically significant. The 2%/2 mm-based gamma pass rate (%) of the proposed method was 95.45 ± 1.91, and the comparison methods (ResNet_GAN, sUnet_GAN, and FCN_GAN) were 93.33 ± 1.20, 89.64 ± 1.63, and 87.31 ± 1.94, respectively. Significance. The pseudo-CT images obtained based on MD-CycleGAN have higher imaging quality and are closer to the CT gt in terms of anatomy and dosimetry than other GAN models.

CT synthesis from MR images using frequency attention conditional generative adversarial network

A Novel Method Of Synthetic Ct Generation From Mr Images Based On Convolutional Neural Networks

Synthesizing Contrast-enhanced Computed Tomography Images with an Improved Conditional Generative Adversarial Network

Synthetic CT generation from cone-beam CT using deep-learning for breast adaptive radiotherapy

CT synthesis from MR in the pelvic area using Residual Transformer Conditional GAN

MRI-based Synthetic CT Generation Using Deep Convolutional Neural Network

Frequency-Supervised MR-to-CT Image Synthesis

Evaluation of Synthetic CT Image Generated Using a Neural Network for MR-Only Radiotherapy

MR-based Synthetic CT Images Generated Using Generative Adversarial Networks for Nasopharyngeal Carcinoma Radiotherapy Treatment Planning

CBCT-Based Synthetic MRI Generation for CBCT-Guided Adaptive Radiotherapy.

CT synthesis from MRI using multi-cycle GAN for head-and-neck radiation therapy

Synthetic CT generation for pelvic cases based on deep learning in multi-center datasets

Frequency-Selective Learning for CT to MR Synthesis.

MR-based synthetic CT image for intensity-modulated proton treatment planning of nasopharyngeal carcinoma patients

Mask-guided generative adversarial network for MRI-based CT synthesis

Spatially Invariant and Frequency-Aware CycleGAN for Unsupervised MR-to-CT Synthesis

GLFA-NET: A Hybrid Network for Mr-To-Ct Synthesis Via Global and Local Feature Aggregation

Medical Image Synthesis with Context-Aware Generative Adversarial Networks

Synthesis of pseudo-CT images from pelvic MRI images based on an MD-CycleGAN model for radiotherapy

Synthetic computed tomography generation from multi-sequence magnetic resonance images for nasopharyngeal carcinoma treatment planning via cycle-consistent generative adversarial network

Multi-sequence MR Image-Based Synthetic CT Generation Using a Generative Adversarial Network for Head and Neck MRI-only Radiotherapy